Abstract
Immune dysfunction, including monocytosis, increased blood levels of interleukin-1 (IL-1), interleukin-6 (IL- 6) and tumor necrosis factor-alpha (TNF-alpha), as well as an increased microglial density in certain brain areas, have been described in schizophrenia and depression. Interestingly, similar immune alterations have been observed in suicide patients regardless of their underlying psychiatric diagnosis. This review summarizes relevant data from previous studies that have examined peripheral blood, cerebrospinal fluid and human brains (using postmortem histology and in vivo positron emission tomography) to investigate immune mechanisms in suicidal patients.
We discuss whether the observed findings indicate that microgliosis and monocyte-macrophage system activation may be a useful marker of disease acuity/severity or whether they instead indicate a distinct neurobiology of suicide. Notably, pathophysiological mechanisms could change during the long-term course of psychiatric diseases. Therefore, different patterns of immune activation may be observed when comparing newly diseased patients with those who are chronically ill.
Keywords: Suicide, suicidality, depression, schizophrenia, immune system, microglia, mononuclear phagocyte system, monocytes, lymphocytes, review.
CNS & Neurological Disorders - Drug Targets
Title:Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior
Volume: 12 Issue: 7
Author(s): Johann Steiner, Tomasz Gos, Bernhard Bogerts, Hendrik Bielau, Hemmo A. Drexhage and Hans-Gert Bernstein
Affiliation:
Keywords: Suicide, suicidality, depression, schizophrenia, immune system, microglia, mononuclear phagocyte system, monocytes, lymphocytes, review.
Abstract: Immune dysfunction, including monocytosis, increased blood levels of interleukin-1 (IL-1), interleukin-6 (IL- 6) and tumor necrosis factor-alpha (TNF-alpha), as well as an increased microglial density in certain brain areas, have been described in schizophrenia and depression. Interestingly, similar immune alterations have been observed in suicide patients regardless of their underlying psychiatric diagnosis. This review summarizes relevant data from previous studies that have examined peripheral blood, cerebrospinal fluid and human brains (using postmortem histology and in vivo positron emission tomography) to investigate immune mechanisms in suicidal patients.
We discuss whether the observed findings indicate that microgliosis and monocyte-macrophage system activation may be a useful marker of disease acuity/severity or whether they instead indicate a distinct neurobiology of suicide. Notably, pathophysiological mechanisms could change during the long-term course of psychiatric diseases. Therefore, different patterns of immune activation may be observed when comparing newly diseased patients with those who are chronically ill.
Export Options
About this article
Cite this article as:
Steiner Johann, Gos Tomasz, Bogerts Bernhard, Bielau Hendrik, Drexhage A. Hemmo and Bernstein Hans-Gert, Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior, CNS & Neurological Disorders - Drug Targets 2013; 12 (7) . https://dx.doi.org/10.2174/18715273113129990099
DOI https://dx.doi.org/10.2174/18715273113129990099 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Factors Induced by Filoviruses that Lead to Immune Supression
Current Molecular Medicine Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Current Pharmaceutical Design Selection and Evaluation of the Pediatric Epilepsy Surgical Candidates
Current Pediatric Reviews HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Inflammatory Network
Inflammation & Allergy - Drug Targets (Discontinued) Advances in the Development of Inactivated Virus Vaccines
Recent Patents on Anti-Infective Drug Discovery mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Antidepressants and Sleep: Neurophysiology and Clinical Correlates
Current Psychiatry Reviews Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19
Current Hypertension Reviews Viral Inactivation Based on Inhibition of Membrane Fusion: Understanding the Role of Histidine Protonation to Develop New Viral Vaccines
Protein & Peptide Letters The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia
Current Neurovascular Research CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Current Stem Cell Research & Therapy Computational Drug Repositioning by Target Hopping: A Use Case in Chagas Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Recent Advances in the Development of Antiviral Agents Using Computer-aided Structure Based Approaches
Current Pharmaceutical Design The Role of Retroviral dUTPases in Replication and Virulence
Current Protein & Peptide Science T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design